Medications with Generic Name Beginning ‘L’, Page 25

Page 25 of 320 « First Page « … 5 10 15 20 … 23 24 25 26 27 … 30 35 40 45 50 … » Last Page »

LAMIVUDINE and ZIDOVUDINE

Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1…

Camber Pharmaceuticals, Inc.31 July 2020

COMBIVIR (Lamivudine and Zidovudine)

COMBIVIR, a combination of 2 nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection…

ViiV Healthcare Company10 May 2019

LAMIVUDINE and ZIDOVUDINE

Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1…

PD-Rx Pharmaceuticals, Inc.1 October 2020

Lamivudine and Zidovudine

Lamivudine and Zidovudine tablets, a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type…

American Health Packaging6 October 2020

LAMIVUDINE and ZIDOVUDINE

Lamivudine and Zidovudine tablet USP a combination of two nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus…

NuCare Pharmaceuticals,Inc.12 October 2020

Page 25 of 320 « First Page « … 5 10 15 20 … 23 24 25 26 27 … 30 35 40 45 50 … » Last Page »

FDA Medwatch

Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Sun, 24 Jan 2021. Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic…
Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation
Sun, 10 Jan 2021. Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system. The voluntary…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.